Acute graft versus host disease grade II-IV

Clinical trials for Acute graft versus host disease grade II-IV explained in plain language.

Never miss a new study

Get alerted when new Acute graft versus host disease grade II-IV trials appear

Sign up with your email to follow new studies for Acute graft versus host disease grade II-IV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1 Terminated 1

New hope for GVHD patients who fail standard therapy?

Disease control Not yet recruiting

This study tests a new drug called gecacitinib for people with acute graft-versus-host disease (GVHD) after a stem cell transplant. It is for those who did not get better or could not tolerate the usual second-line treatment. The trial will include 15 adults and aims to see if th…

Matched conditions: ACUTE GRAFT VERSUS HOST DISEASE GRADE II-IV

Phase 2 • Sponsor: Ruijin Hospital • Aim: Disease control

Last updated Jun 27, 2026 07:52 UTC

Acute graft versus host disease grade II-IV

Get alerted when new Acute graft versus host disease grade II-IV trials appear

New hope for GVHD patients who fail standard therapy?